DNA

STRATA Skin Sciences to Report First Quarter 2025 Financial Results on May 14, 2025 and Provide Corporate Update

HORSHAM, Pa., May 07, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical…

8 months ago

Actuate Therapeutics to Host KOL Event on Topline Phase 2 Data of Elraglusib in Metastatic Pancreatic Ductal Adenocarcinoma During ASCO Annual Meeting

Fireside discussion to explore clinical impact of the topline Phase 2 data in first-line metastatic pancreatic ductal adenocarcinoma (mPDAC) to…

8 months ago

Belite Bio to Host Webcast on May 14, 2025, to Discuss First Quarter 2025 Financial Results

SAN DIEGO, May 07, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused…

8 months ago

NewGenIVF Introduces NewGenSort to Support Men’s Reproductive Health Across Asia

MicroSort® has been rebranded as NewGenSort as the technology becomes a more integral part of NewGen’s product offeringsBANGKOK, May 07,…

8 months ago

Plasmidsaurus Opens 10th Global Lab in Singapore, Scaling to Meet the Demand for Cutting-Edge Sequencing Around the World

SINGAPORE and SOUTH SAN FRANCISCO, Calif., May 6, 2025 /PRNewswire/ -- Plasmidsaurus, the company that sequences while you sleep, today…

8 months ago

Caresyntax and The Jacobs Institute Announce Strategic Collaboration to Advance Surgical Insights and Real-World Evidence Generation

BUFFALO, N.Y., May 6, 2025 /PRNewswire/ -- Caresyntax Corporation, a leader in surgical data integration and intelligence, and The Jacobs Institute,…

8 months ago

Specific Biologics Inc. to Present Dualase® Genome Editing for the Precise Removal of Pathogenic Repeats in Repeat Expansion Disorders at the 28th Annual American Society for Gene and Cell Therapy Meeting

TORONTO, May 6, 2025 /PRNewswire/ - Specific Biologics Inc., a biotechnology company advancing industry leading genome editing therapies, today announced…

8 months ago

Factor Bioscience to Present Non-Viral Gene Editing and Cell Engineering Innovations at the ASGCT Annual Meeting

Presentations will include latest data from Factor's allogeneic CAR-T cell therapy programsCAMBRIDGE, Mass., May 6, 2025 /PRNewswire/ -- Factor Bioscience Inc.,…

8 months ago

Alphabiome Launches Groundbreaking AI Technology that Deciphers the Genetic Code of the Microbiome

Founding team includes biochemistry Nobel Laureates and world-leading AI experts Proprietary AI technology transforms untapped microbial genetic data into actionable…

8 months ago